688399.SH
硕世生物
SSE · Healthcare · Biotechnology · CN
CNY 27.85
−2.76%Margins
Gross margin
63.6%
EBITDA margin
15.0%
EBIT margin
-5.7%
Net margin
-10.1%
FCF margin
-21.5%
-1.1%
Return on equity
-0.9%
Return on assets
-0.5%
Return on invested capital
0.09x
Asset turnover
CNY 23.4M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026